Please provide your email address to receive an email when new articles are posted on . Remote reprogramming for implantable cardiac devices was associated with an improvement in clinic workflow.
The U.S. Food and Drug Administration gave Minneapolis-based Medtronic 510(k) clearance for its Reveal LINQ Insertable Cardiac Monitoring system, according to a news release. At one-third the size of ...
AccuRhythm AI algorithms now cleared by FDA for the Reveal LINQ ICM; enhancements made to the AF algorithm for the LINQ II ICM MedTech Breakthrough, an independent market intelligence organization ...
Abbott (ABT)'s Assert-IQ offers the world's longest battery life† for an insertable cardiac monitor (ICM) The latest addition to Abbott's portfolio of connected health devices, the Assert-IQ ICM ...
Please provide your email address to receive an email when new articles are posted on . Insertable cardiac monitoring was estimated to be cost-effective for AF detection in the U.S. This finding was ...
Medtronic said its AccuRhythm AI algorithm technology is the winner of the 7 th annual MedTech Breakthrough Awards program as the "Best New Monitoring Solution." AccuRhythm AI is an artificial ...
Jennifer Adamy, a 43-year-old cardiac nurse living in New Smyrna Beach, Florida, was very familiar with the signs of heart problems. So, when she started experiencing symptoms of irregular heart ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback